Long ‐term safety and efficacy of the novel β3‐adrenoreceptor agonist vibegron in Japanese patients with overactive bladder: A phase III prospective study
International Journal of Urology, EarlyView.
Source: International Journal of Urology - Category: Urology & Nephrology Authors: Masaki Yoshida
,
Hidehiro Kakizaki
,
Satoru Takahashi
,
Shinji Nagai
,
Takafumi Kurose Source Type: research
More News: Japan Health | Overactive Bladder | Overactive Bladder Syndrome | Study | Urology & Nephrology